Leube J. | Pharma Division Nonclinical Development F. Hoffmann-la Roche Ltd.
スポンサーリンク
概要
関連著者
-
Leube J.
Pharma Division Nonclinical Development F. Hoffmann-la Roche Ltd.
-
Heizmann P.
Pharma Division Nonclinical Development F. Hoffmann-la Roche Ltd.
-
SCHMITT M.
Pharma Division, Nonclinical Development, F. Hoffmann-La Roche Ltd.
-
LEUBE J.
Pharma Division, Nonclinical Development, F. Hoffmann-La Roche Ltd.
-
MARTIN H.
Pharma Division, Nonclinical Development, F. Hoffmann-La Roche Ltd.
-
SANER A.
Pharma Division, Nonclinical Development, F. Hoffmann-La Roche Ltd.
-
Schmitt M.
Pharma Division Nonclinical Development F. Hoffmann-la Roche Ltd.
-
Fischer G.
Pharma Division Preclinical Research
-
Saner A.
Pharma Division Nonclinical Development F. Hoffmann-la Roche Ltd.
-
Martin H.
Pharma Division Nonclinical Development F. Hoffmann-la Roche Ltd.
著作論文
- Determination of the catechol-O-methyltransferase inhibitor tolcapone and three of its metabolites in animal and human plasma and urine by reversed-phase high-performance liquid chromatography with ultraviolet detection
- Determination of the renin inhibitor Ro 42-5892 in human plasma by automated pre-column derivatization, reversed-phase high-performance liquid chromatographic separation and electrochemical detection after post-column irradiation